BMY Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-04-01 | Shanahan Karin | officer: EVP, Glob. Prod. Dev. & Supply | 6,613 | M-Exempt | D | 3,306 | 0.00 | 0.00 |
| 2024-04-01 | Shanahan Karin | officer: EVP, Glob. Prod. Dev. & Supply | 6,532 | M-Exempt | A | 3,306 | 0.00 | 0.00 |
| 2024-04-01 | Shanahan Karin | officer: EVP, Glob. Prod. Dev. & Supply | 5,336 | F-InKind | D | 1,196 | 52.99 | 63,376.00 |
| 2024-03-31 | YALE PHYLLIS R | director | 27,595.249 | A-Award | A | 645.399 | 0.00 | 0.00 |
| 2024-03-31 | Storch Gerald L | director | 88,158.649 | A-Award | A | 691.499 | 0.00 | 0.00 |
| 2024-03-31 | Samuels Theodore R. II | director | 47,858.919 | A-Award | A | 921.999 | 0.00 | 0.00 |
| 2024-03-31 | Rice Derica W | director | 23,634.109 | A-Award | A | 691.499 | 0.00 | 0.00 |
| 2024-03-31 | Bhatt Deepak | director | 10,050.37 | A-Award | A | 161.35 | 0.00 | 0.00 |
| 2024-03-31 | Arduini Peter J | director | 52,708.649 | A-Award | A | 645.399 | 0.00 | 0.00 |
| 2024-03-10 | Lenkowsky Adam | officer: EVP, Chief Commercial Officer | 31,347 | A-Award | A | 31,347 | 0.00 | 0.00 |
| 2024-03-10 | Lenkowsky Adam | officer: EVP, Chief Commercial Officer | 20,898 | A-Award | A | 20,898 | 0.00 | 0.00 |
| 2024-03-10 | Lenkowsky Adam | officer: EVP, Chief Commercial Officer | 13,859 | M-Exempt | A | 11,416 | 0.00 | 0.00 |
| 2024-03-10 | Lenkowsky Adam | officer: EVP, Chief Commercial Officer | 9,885 | J-Other | D | 3,974 | 0.00 | 0.00 |
| 2024-03-10 | Lenkowsky Adam | officer: EVP, Chief Commercial Officer | 6,650 | F-InKind | D | 3,235 | 53.79 | 174,011.00 |
| 2024-03-10 | Lenkowsky Adam | officer: EVP, Chief Commercial Officer | 6,001 | J-Other | D | 2,000 | 0.00 | 0.00 |
| 2024-03-10 | Lenkowsky Adam | officer: EVP, Chief Commercial Officer | 3,653 | J-Other | D | 1,825 | 0.00 | 0.00 |
| 2024-03-10 | Lenkowsky Adam | officer: EVP, Chief Commercial Officer | 3,341 | M-Exempt | A | 1,902 | 0.00 | 0.00 |
| 2024-03-10 | Lenkowsky Adam | officer: EVP, Chief Commercial Officer | 3,013 | J-Other | D | 328 | 0.00 | 0.00 |
| 2024-03-10 | Lenkowsky Adam | officer: EVP, Chief Commercial Officer | 2,443 | F-InKind | D | 570 | 53.79 | 30,660.00 |
| 2024-03-10 | Lenkowsky Adam | officer: EVP, Chief Commercial Officer | 2,224 | M-Exempt | A | 1,698 | 0.00 | 0.00 |
| 2024-03-10 | Lenkowsky Adam | officer: EVP, Chief Commercial Officer | 1,957 | J-Other | D | 267 | 0.00 | 0.00 |
| 2024-03-10 | Lenkowsky Adam | officer: EVP, Chief Commercial Officer | 1,904 | M-Exempt | D | 1,902 | 0.00 | 0.00 |
| 2024-03-10 | Lenkowsky Adam | officer: EVP, Chief Commercial Officer | 1,439 | F-InKind | D | 518 | 53.79 | 27,863.00 |
| 2024-03-10 | Lenkowsky Adam | officer: EVP, Chief Commercial Officer | 0 | M-Exempt | D | 1,698 | 0.00 | 0.00 |
| 2024-03-10 | Lenkowsky Adam | officer: EVP, Chief Commercial Officer | 0 | M-Exempt | D | 11,416 | 0.00 | 0.00 |
| 2024-03-10 | LEUNG SANDRA | officer: EVP, General Counsel | 371,312.333 | M-Exempt | A | 35,139 | 0.00 | 0.00 |
| 2024-03-10 | LEUNG SANDRA | officer: EVP, General Counsel | 359,080.333 | J-Other | D | 12,232 | 0.00 | 0.00 |
| 2024-03-10 | LEUNG SANDRA | officer: EVP, General Counsel | 347,385.333 | F-InKind | D | 11,695 | 53.79 | 629,074.00 |
| 2024-03-10 | LEUNG SANDRA | officer: EVP, General Counsel | 339,657.333 | M-Exempt | A | 5,856 | 0.00 | 0.00 |
| 2024-03-10 | LEUNG SANDRA | officer: EVP, General Counsel | 338,648.333 | J-Other | D | 1,009 | 0.00 | 0.00 |
| 2024-03-10 | LEUNG SANDRA | officer: EVP, General Counsel | 337,203.333 | M-Exempt | A | 5,789 | 0.00 | 0.00 |
| 2024-03-10 | LEUNG SANDRA | officer: EVP, General Counsel | 336,291.333 | J-Other | D | 912 | 0.00 | 0.00 |
| 2024-03-10 | LEUNG SANDRA | officer: EVP, General Counsel | 336,173.333 | F-InKind | D | 2,475 | 53.79 | 133,130.00 |
| 2024-03-10 | LEUNG SANDRA | officer: EVP, General Counsel | 333,801.333 | F-InKind | D | 2,490 | 53.79 | 133,937.00 |
| 2024-03-10 | LEUNG SANDRA | officer: EVP, General Counsel | 42,957 | A-Award | A | 42,957 | 0.00 | 0.00 |
| 2024-03-10 | LEUNG SANDRA | officer: EVP, General Counsel | 28,638 | A-Award | A | 28,638 | 0.00 | 0.00 |
| 2024-03-10 | LEUNG SANDRA | officer: EVP, General Counsel | 16,248 | J-Other | D | 5,415 | 0.00 | 0.00 |
| 2024-03-10 | LEUNG SANDRA | officer: EVP, General Counsel | 10,700 | J-Other | D | 5,349 | 0.00 | 0.00 |
| 2024-03-10 | LEUNG SANDRA | officer: EVP, General Counsel | 5,858 | M-Exempt | D | 5,856 | 0.00 | 0.00 |
| 2024-03-10 | LEUNG SANDRA | officer: EVP, General Counsel | 0 | M-Exempt | D | 35,139 | 0.00 | 0.00 |
| 2024-03-10 | LEUNG SANDRA | officer: EVP, General Counsel | 0 | M-Exempt | D | 5,789 | 0.00 | 0.00 |
| 2024-03-10 | Plenge Robert M | officer: EVP, Chief Research Officer | 23,220 | A-Award | A | 23,220 | 0.00 | 0.00 |
| 2024-03-10 | Plenge Robert M | officer: EVP, Chief Research Officer | 15,480 | A-Award | A | 15,480 | 0.00 | 0.00 |
| 2024-03-10 | Plenge Robert M | officer: EVP, Chief Research Officer | 15,182 | M-Exempt | A | 6,985 | 0.00 | 0.00 |
| 2024-03-10 | Plenge Robert M | officer: EVP, Chief Research Officer | 12,751 | J-Other | D | 2,431 | 0.00 | 0.00 |
| 2024-03-10 | Plenge Robert M | officer: EVP, Chief Research Officer | 11,315 | F-InKind | D | 1,436 | 53.79 | 77,242.00 |
| 2024-03-10 | Plenge Robert M | officer: EVP, Chief Research Officer | 8,681 | M-Exempt | A | 1,164 | 0.00 | 0.00 |
| 2024-03-10 | Plenge Robert M | officer: EVP, Chief Research Officer | 8,480 | J-Other | D | 201 | 0.00 | 0.00 |
| 2024-03-10 | Plenge Robert M | officer: EVP, Chief Research Officer | 8,197 | F-InKind | D | 283 | 53.79 | 15,223.00 |
| 2024-03-10 | Plenge Robert M | officer: EVP, Chief Research Officer | 7,920 | M-Exempt | A | 994 | 0.00 | 0.00 |
| 2024-03-10 | Plenge Robert M | officer: EVP, Chief Research Officer | 7,763 | J-Other | D | 157 | 0.00 | 0.00 |
| 2024-03-10 | Plenge Robert M | officer: EVP, Chief Research Officer | 7,517 | F-InKind | D | 246 | 53.79 | 13,232.00 |
| 2024-03-10 | Plenge Robert M | officer: EVP, Chief Research Officer | 7,026 | J-Other | D | 2,342 | 0.00 | 0.00 |
| 2024-03-10 | Plenge Robert M | officer: EVP, Chief Research Officer | 2,214 | J-Other | D | 1,107 | 0.00 | 0.00 |
| 2024-03-10 | Plenge Robert M | officer: EVP, Chief Research Officer | 1,165 | M-Exempt | D | 1,164 | 0.00 | 0.00 |
| 2024-03-10 | Plenge Robert M | officer: EVP, Chief Research Officer | 0 | M-Exempt | D | 6,985 | 0.00 | 0.00 |
| 2024-03-10 | Plenge Robert M | officer: EVP, Chief Research Officer | 0 | M-Exempt | D | 994 | 0.00 | 0.00 |
| 2024-03-10 | Poole Ahn Amanda | officer: EVP, Chief Human Resources | 17,096 | A-Award | A | 17,096 | 0.00 | 0.00 |
| 2024-03-10 | Poole Ahn Amanda | officer: EVP, Chief Human Resources | 11,397 | A-Award | A | 11,397 | 0.00 | 0.00 |
| 2024-03-10 | Poole Ahn Amanda | officer: EVP, Chief Human Resources | 4,841 | M-Exempt | A | 4,140 | 0.00 | 0.00 |
| 2024-03-10 | Poole Ahn Amanda | officer: EVP, Chief Human Resources | 3,400 | J-Other | D | 1,441 | 0.00 | 0.00 |
| 2024-03-10 | Poole Ahn Amanda | officer: EVP, Chief Human Resources | 2,424 | F-InKind | D | 976 | 53.79 | 52,499.00 |
| 2024-03-10 | Poole Ahn Amanda | officer: EVP, Chief Human Resources | 2,411 | J-Other | D | 803 | 0.00 | 0.00 |
| 2024-03-10 | Poole Ahn Amanda | officer: EVP, Chief Human Resources | 1,621 | J-Other | D | 810 | 0.00 | 0.00 |
| 2024-03-10 | Poole Ahn Amanda | officer: EVP, Chief Human Resources | 1,027 | M-Exempt | A | 690 | 0.00 | 0.00 |
| 2024-03-10 | Poole Ahn Amanda | officer: EVP, Chief Human Resources | 908 | J-Other | D | 119 | 0.00 | 0.00 |
| 2024-03-10 | Poole Ahn Amanda | officer: EVP, Chief Human Resources | 701 | F-InKind | D | 207 | 53.79 | 11,135.00 |
| 2024-03-10 | Poole Ahn Amanda | officer: EVP, Chief Human Resources | 690 | M-Exempt | D | 690 | 0.00 | 0.00 |
| 2024-03-10 | Poole Ahn Amanda | officer: EVP, Chief Human Resources | 628 | M-Exempt | A | 628 | 0.00 | 0.00 |
| 2024-03-10 | Poole Ahn Amanda | officer: EVP, Chief Human Resources | 529 | J-Other | D | 99 | 0.00 | 0.00 |
| 2024-03-10 | Poole Ahn Amanda | officer: EVP, Chief Human Resources | 337 | F-InKind | D | 192 | 53.79 | 10,328.00 |
| 2024-03-10 | Poole Ahn Amanda | officer: EVP, Chief Human Resources | 0 | M-Exempt | D | 628 | 0.00 | 0.00 |
| 2024-03-10 | Poole Ahn Amanda | officer: EVP, Chief Human Resources | 0 | M-Exempt | D | 4,140 | 0.00 | 0.00 |
| 2024-03-10 | Hirawat Samit | officer: EVP,Chief Med.Offr.,Drug Dev. | 80,256 | M-Exempt | A | 29,311 | 0.00 | 0.00 |
| 2024-03-10 | Hirawat Samit | officer: EVP,Chief Med.Offr.,Drug Dev. | 70,053 | J-Other | D | 10,203 | 0.00 | 0.00 |
| 2024-03-10 | Hirawat Samit | officer: EVP,Chief Med.Offr.,Drug Dev. | 60,952 | A-Award | A | 60,952 | 0.00 | 0.00 |
| 2024-03-10 | Hirawat Samit | officer: EVP,Chief Med.Offr.,Drug Dev. | 60,279 | F-InKind | D | 9,774 | 53.79 | 525,743.00 |
| 2024-03-10 | Hirawat Samit | officer: EVP,Chief Med.Offr.,Drug Dev. | 53,855 | M-Exempt | A | 4,885 | 0.00 | 0.00 |
| 2024-03-10 | Hirawat Samit | officer: EVP,Chief Med.Offr.,Drug Dev. | 53,013 | J-Other | D | 842 | 0.00 | 0.00 |
| 2024-03-10 | Hirawat Samit | officer: EVP,Chief Med.Offr.,Drug Dev. | 51,437 | M-Exempt | A | 4,192 | 0.00 | 0.00 |
| 2024-03-10 | Hirawat Samit | officer: EVP,Chief Med.Offr.,Drug Dev. | 50,945 | F-InKind | D | 2,068 | 53.79 | 111,238.00 |
| 2024-03-10 | Hirawat Samit | officer: EVP,Chief Med.Offr.,Drug Dev. | 50,777 | J-Other | D | 660 | 0.00 | 0.00 |
| 2024-03-10 | Hirawat Samit | officer: EVP,Chief Med.Offr.,Drug Dev. | 48,970 | F-InKind | D | 1,807 | 53.79 | 97,199.00 |
| 2024-03-10 | Hirawat Samit | officer: EVP,Chief Med.Offr.,Drug Dev. | 40,635 | A-Award | A | 40,635 | 0.00 | 0.00 |
| 2024-03-10 | Hirawat Samit | officer: EVP,Chief Med.Offr.,Drug Dev. | 17,565 | J-Other | D | 5,854 | 0.00 | 0.00 |
| 2024-03-10 | Hirawat Samit | officer: EVP,Chief Med.Offr.,Drug Dev. | 9,532 | J-Other | D | 4,765 | 0.00 | 0.00 |
| 2024-03-10 | Hirawat Samit | officer: EVP,Chief Med.Offr.,Drug Dev. | 4,886 | M-Exempt | D | 4,885 | 0.00 | 0.00 |
| 2024-03-10 | Hirawat Samit | officer: EVP,Chief Med.Offr.,Drug Dev. | 0 | M-Exempt | D | 4,192 | 0.00 | 0.00 |
| 2024-03-10 | Hirawat Samit | officer: EVP,Chief Med.Offr.,Drug Dev. | 0 | M-Exempt | D | 29,311 | 0.00 | 0.00 |
| 2024-03-10 | Holzer Phil M | officer: SVP and Controller | 14,916 | M-Exempt | A | 4,206 | 0.00 | 0.00 |
| 2024-03-10 | Holzer Phil M | officer: SVP and Controller | 13,452 | J-Other | D | 1,464 | 0.00 | 0.00 |
| 2024-03-10 | Holzer Phil M | officer: SVP and Controller | 12,460 | F-InKind | D | 992 | 53.79 | 53,360.00 |
| 2024-03-10 | Holzer Phil M | officer: SVP and Controller | 11,041 | M-Exempt | A | 701 | 0.00 | 0.00 |
| 2024-03-10 | Holzer Phil M | officer: SVP and Controller | 10,920 | J-Other | D | 121 | 0.00 | 0.00 |
| 2024-03-10 | Holzer Phil M | officer: SVP and Controller | 10,710 | F-InKind | D | 210 | 53.79 | 11,296.00 |
| 2024-03-10 | Holzer Phil M | officer: SVP and Controller | 10,624 | M-Exempt | A | 613 | 0.00 | 0.00 |
| 2024-03-10 | Holzer Phil M | officer: SVP and Controller | 10,527 | J-Other | D | 97 | 0.00 | 0.00 |
| 2024-03-10 | Holzer Phil M | officer: SVP and Controller | 10,340 | F-InKind | D | 187 | 53.79 | 10,059.00 |
| 2024-03-10 | Holzer Phil M | officer: SVP and Controller | 7,407 | A-Award | A | 7,407 | 0.00 | 0.00 |
| 2024-03-10 | Holzer Phil M | officer: SVP and Controller | 4,938 | A-Award | A | 4,938 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
